GHK-Cu
Copper-bound GHK; Glycyl-L-histidyl-L-lysine copper complex
Source type: Cell study. Sources checked .
What the cited research examined
GHK-Cu was studied for collagen synthesis in fibroblast cultures.
Cell-culture findings do not establish injectable benefits, systemic exposure, or storage specifications for commercial products.
Reference facts
- Half-life
- Not established for general human use by the cited source.
- Human dose range
- Not provided. This reference does not recommend a human dose.
- Administration interval
- Not established by these sources. A half-life is not a dosing schedule.
- Storage
- Product-specific information required. These sources do not establish a storage specification.
Safety context
FDA raises injectable immune concerns with limited human data.
Research results and substance listings are not product approvals. The FDA overview distinguishes current Category 2 entries from withdrawn nominations; withdrawal does not establish safety.
Sources and review method
- Fibroblast collagen synthesis experiment
- FDA: bulk substances with potential safety risks (includes withdrawn nominations)
These are bounded summaries of the linked sources, not systematic reviews. An unknown field means that these sources do not establish a general-use value. It does not claim that no other literature exists.
The calculator converts values you provide. The planner organizes entries you choose. Neither tool assesses whether a substance or schedule is appropriate.